Biofil Chemicals and Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing and trading pharmaceutical products. The Company operates through two segments: the Pharmaceutical Division and the Chemicals Division. It is also involved in the business activity of producing plastic products, which are used for the purpose of packing pharmaceutical product and other plastic products. The Company’s product categories include Basic Drugs & Chemicals, and Plastic Dripper & Caps. Its Basic Drugs & Chemicals include Sodium Chloride, Potassium Chloride, Sodium Citrate, Diethyl Carbamazine Citrate, Ferrous Sulphate, Dried Ferrous Sulphate, Ferrus Fumerate, Micro Crystalline Cellulose and Dicyclomine Hydrochloride. The Company's plants are located at Kheda Industrial Estate, Pithampur District, Dhar, and Sanwer Road, Industrial Area, Indore in Madhya Pradesh. The Company also deals in providing job work facilities in respect of the manufacturing of pharmaceutical drugs.
Biofil Chem & Pharma Financial Highlights
- Revenue: Biofil Chem & Pharma reported revenue of ₹31.48 crore in FY26 vs ₹33.71 crore in FY25. It showed a decrease of 6.62% on a yearly basis.
- Operating Profit: Biofil Chem & Pharma reported an operating profit of ₹3.45 crore in FY26 vs ₹0.74 crore in FY25. It showed an increase of 366.22% on a year-on-year basis.
- Net Profit: Biofil Chem & Pharma reported a net profit of ₹2.79 crore in FY26 vs ₹0.56 crore in FY25. It showed an increase of 398.21% on a yearly basis.
Biofil Chem & Pharma Quarterly Result Highlights
- Biofil Chem & Pharma reported revenue of ₹7.68 crore in Mar 2026, compared with ₹0.94 crore in Dec 2025, representing an increase of 717.02% on a quarter-on-quarter (QoQ) basis.
- Biofil Chem & Pharma reported an operating profit of ₹0.47 crore in Mar 2026, compared with ₹0.11 crore in Dec 2025, representing an increase of 327.27% on a quarter-on-quarter (QoQ) basis.
- Biofil Chem & Pharma reported a profit of ₹0.21 crore in Mar 2026, compared with ₹0.08 crore in Dec 2025, reflecting an increase of 162.50% on a QoQ basis.
- The earnings per share (EPS) of Biofil Chem & Pharma stood at ₹0.34 during Mar 2026.